“…At the preoperative imaging, 414 (79.3%) patients had patent false lumens, 84 (16.1%) had partial thrombosis of the false lumen, and 24 (4.6%) had complete thrombosis of the false lumen. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…DATA SOURCES: Annual reports of the Therapeutic Products Directorate and the Biologic and Genetic Therapies Directorate; evaluations of therapeutic innovation from the Patented Medicine Prices Review Board and Prescrire International; MedEffect Canada website. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Since the expiration of the patent for Prograf(®), generic preparations have been approved in Europe as bioequivalence has been shown in healthy volunteers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We will search electronic databases and the grey literature using a predefined search strategy to identify randomised and non-randomised studies, technical reports and patents. Searches will not be restricted by language or date and will be expanded through contact with authors and experts, and by following up reference lists and citations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We then found that administration of compound C to male global 11β-HSD1 knockout mice elicited improvements in metabolic parameters, suggesting “off-target” mechanisms. Based on the patent literature, we synthesized another 11β-HSD1 inhibitor (MK-0916) from a different chemical series and showed that it too had similar off-target body weight and food intake effects at high doses. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Coronary CT angiography in 96 re-evaluated patients showed that all ITAs, right or left, used in situ for the left anterior descending were patent. There were no deaths in either group. CONCLUSION: Coronary artery bypass grafting surgery involving anastomosis of the anteroaortic right internal thoracic artery to the left anterior descending artery has an outcome similar to that obtained using the left internal thoracic artery for the same coronary site.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The combined results of available ventilation modes were not significantly different in regard to the incidences of patent ductus arteriosus and intraventricular hemorrhage. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…However, the VPA Css in patents who gained weight were not significantly different from those who did not gain weight (p = 0.121). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Fifty-three subacute stroke patents were enrolled. Ambulatory function was assessed by gait speed and endurance. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSIONS: The T. vivax infection in Zebu bulls from CSAI caused patent parasitemia, induced a febrile state, promoted reduction in the libido and increased the ejaculate volume. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Major adverse events occurred in 5 patients (5.6%) of the PCI group and in 17 patents (19.5%) of the OMT group (p=0.015). There were no significant differences between the PCI group and the OMT group in cardiac death [hazard ratio (HR) for the PCI group 0.454; 95% confidence interval (CI) 0.041–5.019, p=0.520], myocardial infarction (HR 0.399; 95% CI 0.039–4.050, p=0.437), or stroke (HR 0.919; 95% CI 0.057–14.709, p=0.952). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Discrepancy rates between the EHR extraction and the manual database were calculated for gestational age in weeks (2.6 %), birthweight (9.7 %), first white blood cell count (3.2 %), initial hemoglobin (11.9 %), peak total and direct bilirubin (11.4 % and 4.9 %), and patent ductus arteriosus (PDA) diagnosis (12.8 %). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSIONS: We report of a case in whom microfilariae were detected in fine-needle aspirate of subcutaneous node, without evidence of microfilaraemia, and the infection failed to become fully patent. Therefore we confirm that complete development and fertilization of D. repens worms in human hosts may occur, at variance with what is commonly believed, that Dirofilaria worms cannot fully develop in humans. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSION: When imatinib loses patent protection and its price declines, its use will be the cost-effective initial treatment strategy for CML-CP.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The first approved biosimilar medicines were small proteins, and more recently biosimilar versions of innovator monoclonal antibody (mAb) drugs have entered development as patents on these more complex proteins expire. In September 2013, the first biosimilar mAb, infliximab, was authorised in Europe. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: PDA(Patent ductus arteriosus) is a common and clinically important condition which is presented with a number of hemodynamic and respiratory problems such as intraventricular hemorrhage, pulmonary hemorrhage and necrotizing enterocolitis due to increased pulmonary blood flow and stealing from systemic circulation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All non-protected volunteers developed symptoms 8–13 days after CHMI with a mean pre-patent period of 12.8 days. No serious adverse events related to the immunizations were observed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Twenty-one (75%) had severe mitral stenosis (MS) including severe tricuspid regurgitation (n = 13, 61%), ventricular septal defect (VSD, n = 3, 14%), complete endocardial cushion defect (ECD, n = 3, 14%), and mild to moderate mitral regurgitation (MR) (n = 2, 11%), moderate MS and moderate MR were found in four (16%) patients among complete bridge type of DOMV, while all patients with incomplete bridge type had severe MS and patent ductus arteriosus (PDA) as associated lesions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This review also includes detailed information in Additional files 1, 2, 3 for major known Paenibacillus species with their locations of isolation, genome sequencing projects, patents, and industrially significant compounds and enzymes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…At times, maintaining a patent airway may become difficult either due to direct handling during initial airway management or due to surgical intervention. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso